OR WAIT null SECS
September 05, 2013
Baxter and Coherus Biosciences colaborate to develop and commercialize a biosimilar version of etanercept for Europe, Canada, and, Brazil.
September 04, 2013
A roundup of developments in global health and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.
August 29, 2013
Johnson & Johnson completes acquisition deal with Aragon Pharmaceuticals.
James Stewart named CIO of Merck KGaA.
August 28, 2013
The Russian pharmaceutical company PharmaStand finalizes deal for acquiring Bever, a Singapore pharma company.
Sangamo BioSciences has agreed to acquire Ceregene, a privately held biotechnology company focused on developing adeno-associated virus (AAV) gene therapies.
August 26, 2013
Santaris Pharma and Shire have extended their partnership in the rare genetic disease space.
August 14, 2013
Understanding the supply-chain challenge and coupling high-efficiency chromatographic techniques with information-rich detectors are leading to improvements in the management of extractables and leachables in parenteral drugs.
A simple, rapid analytical method for the determination of palladium in pharmaceutical production samples will speed up development and optimization of reactions involving palladium catalysts.
July 30, 2013
Bristol-Myers Squibb Company and Samsung BioLogics announced the companies have entered into a 10-year agreement.